Clinical Characteristics, Including History of MI and Stroke, Among US Post-menopausal Women Initiating Treatment With Romosozumab and Other Anti-osteoporosis Therapies (20190205)

First published 14/09/2020

Last updated 12/05/2025

EU PAS number:

EUPAS37160

Study

Finalised

Documents

Study protocol

Initial protocol

Protocol-Published Amendment romosozumab 20190205 1 (2).pdf

English (1.43 MB - PDF) View document

Study results

Study report

20190205_ORSR_abstract_Redacted.pdf

English (861.9 KB - PDF) View document

Other information

Secondary tabs